DIC Guidelines

Standard operating procedures and protocols for the Drug Information Center

What is a Drug Information Center (DIC)?

A Drug Information Center (DIC) is a specialized service that provides evidence-based, up-to-date pharmaceutical information to healthcare professionals, patients, and the public. It serves as a central hub for answering drug-related queries, evaluating medication therapy, and supporting rational drug use.

🎯 Mission

To provide accurate, unbiased, and timely drug information to improve patient outcomes and promote safe medication practices.

👁️ Vision

To be the leading drug information resource recognized for excellence in pharmaceutical care and evidence-based practice.

💪 Objectives

Enhance medication safety, reduce medication errors, and support clinical decision-making through comprehensive drug information services.

Drug Monographs

Drug monographs are comprehensive, evidence-based summaries of individual medications. Each monograph includes essential information for safe and effective use of the drug.

Typical Monograph Sections:
Generic & Brand Names
Drug Class & Mechanism
Indications & Uses
Dosage & Administration
Contraindications
Precautions & Warnings
Adverse Effects
Drug Interactions
Pharmacokinetics
Pregnancy & Lactation
Storage & Handling
Patient Counseling Points
Monograph Quality Standards
  • All information must be sourced from peer-reviewed literature
  • References must include primary literature and authoritative databases
  • Content must be reviewed and updated at least annually
  • Evidence levels must be clearly rated (A, B, C)

Rx Express Guidelines

Rx Express is the rapid-response service for urgent drug information queries. It is designed for time-sensitive clinical decisions where immediate information is needed at the point of care.

⏱️ Response Times
  • Emergency: Within 1 hour
  • Urgent: Within 4-6 hours
  • Routine: Within 24-48 hours
📋 Eligible Queries
  • Acute overdose management
  • Critical drug interactions
  • Pregnancy/lactation safety
  • Therapeutic alternatives
  • Drug identification

Reference Sources

The DIC utilizes a hierarchy of reference sources to ensure the highest quality of information. Primary sources are preferred over secondary and tertiary sources.

Primary Sources
  • Original research articles
  • Clinical trial results
  • Published case reports
  • Government advisories (FDA, EMA)
Secondary Sources
  • Drug information databases (Lexicomp, Micromedex)
  • Clinical pharmacology reviews
  • Systematic reviews & meta-analyses
  • Practice guidelines
Tertiary Sources
  • Drug handbooks
  • Textbooks of pharmacotherapy
  • Package inserts / prescribing information
  • Formulary compilations

Types of Cases Handled

Drug Identification

Identifying unknown tablets, capsules, or medications based on physical characteristics.

Dosing Queries

Verifying appropriate doses for specific patient populations (renal, hepatic, pediatric, geriatric).

Drug Interactions

Evaluating potential interactions between two or more medications, or with food/herbals.

Adverse Drug Reactions

Assessing causality, mechanism, management, and reporting of adverse reactions.

Pregnancy & Lactation

Providing safety data and risk-benefit analysis for medication use during pregnancy and breastfeeding.

Therapeutic Equivalence

Evaluating generic substitutions and bioequivalence of drug products.

DIC Process Flow

1
Query Received

Request is logged with query number, urgency level, and requester details.

2
Literature Search

Comprehensive search across primary, secondary, and tertiary sources.

3
Information Evaluation

Evidence is critically appraised for quality, validity, and relevance.

4
Formulate Response

A clear, concise, evidence-based response is prepared.

5
Peer Review

A second pharmacist reviews the response for accuracy and completeness.

6
Dispatch & Follow-up

Response is communicated to the requester with documentation and follow-up.

Interprofessional Collaboration

The DIC operates as part of an interprofessional team, collaborating with physicians, nurses, and other healthcare providers to optimize medication therapy and ensure patient safety.

🤝 Collaborative Roles
  • Pharmacists: Lead drug information specialists, clinical pharmacists
  • Physicians: Provide clinical context and therapeutic goals
  • Nurses: Report adverse effects and medication administration issues
  • Laboratory: Support with therapeutic drug monitoring data
📊 Outcomes Tracked
  • Number of queries answered per month
  • Average response time by urgency level
  • Satisfaction ratings from requesters
  • Clinical impact of recommendations
  • Cost savings from therapeutic interventions